We raised antiserum to human recombinant basic fibroblast growth factor (rbFGF) in rabbits. With this affinity-purified antiserum, other antisera to rbFGF, and commercial antiserum to bovine pituitary bFGF, we undertook immunocytochemical detection of bFGF in histological sections of rat mammary glands at different developmental stages. In nongrowing ducts, anti-bFGF serum stains the basement membranelmyoepithelial cells, whereas in serial sections most of this stain is observed to be associated with anti-lamininstaining basement membranes rather than with anti-calluskeratin-staining myoepithelial cells. The weak staining of the myoepithelial cells is enhanced when NiC12 is included in the detection system, but little staining for bFGF is observed in the epithelial cells. In growing neonatal ducts from l-dayold rats, in growing terminal end buds ("Jib) and, to a lesser extent, in growing alveolar buds (ABS) in prepubescent (21day) and pubescent (50-day) rats, both theit inner and outer cells are stained moderately by anti-bFGF sera. In nongrowing ducts from rats aged 6 days, in non-growing ABS KEY WORDS: Developing rat breasts; Basic fibroblast growth factor; Immunocytochemistry; Basement membrane structures and myoepithelial cells; Cells of growing ducts and end buds; Heparinbinding sites. Literature Cited 1. Abraham JA, Whang JL. Tumolo A, Mergia A, Friedman J, Gospodarowicz D, Fiddes JC: Human basic fibroblast growth factor: nucleotide sequence and genomic organisation. EMBO J 5:2523, 1986 2. Adams JC: Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29775, 1981 3. Amann E, Brosius J: ATG vectors for regulated high-level expression of cloned genes in Escherichia coli. Gene 40:183, 1985 4. Baird, A, Ling N: Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a
Introduction
Basic fibroblast growth factor (bFGF) a 16-18 KD polypeptide, is the prototypic member of a family of heparin-binding growth factors and oncogenes (7, 13, 26, 27) . bFGF itself has been purified from a wide variety of tissues and was thought originally to promote the growth of mesodermal and neuroectodermal cells (19, 20) . More recently, bFGF has been shown to be mitogenic and morphogenic for ectoderm-derived cells such as skin epidermal (29, 31, 38) and corneal cells (16, 20) , both in vitro and in vivo. Indeed, bFGF can Supported by the Cancer and Polio Research Fund, by the North West * Correspondence to: Prof. P. S. Rudland of rats aged 60 days and more, and in alveoli from pregnant and lactating rats, only the basement membranelmyoepithelial cell area is stained by anti-bFGF sera; the epithelial cells are unstained. Staining of the myoepithelial cells is enhanced by mixtures of rbFGF and anti-bFGF sera in nongrowing duets, but there is little change in the staining of growing TEBs. All staining by anti-bFGF sera is abolished with heparin in the reactions. We suggest that the immunoreactive bFGF is present mainly bound to heparan sulfate glycosaminoglycans in the basement membrane of resting structures, but that immunoreactive bFGF becomes associated with proliferating cells, particularly those intermediate in characteristics between epithelial and myoepithelial cells in growing structures such as TEBs. (J Histochem Cytochem 41:887-898, 1993) affect the pattern of differentiation of ectodermal precursor cells in cultured early Xenopus embryos (25, 45) . These findings suggest that bFGF may also play an important role in the development of tissues derived from the ectoderm. One of the easiest and most extensively studied ectoderm-derived developmental systems is that of the mammary gland, particularly that of rodents (39).
A major proportion of the development of the rat mammary gland begins before puberty and results in the progressive growth of the mammary duct system within the mammary fat pad (30). During their period of rapid growth, the ducts terminate in terminal end buds (TEBs) which are responsible for new duct growth and also progressively differentiate to alveolar buds (ABS) with each estrous cycle (43) . The ABS are direct precursors to the alveoli, which can synthesize milk products during pregnancy and lactation (43). The different mammary parenchymal cells can be distinguished RUDLAND, PLA'M-HIGGINS, &"SON, FERNIG by ultrastructural and immunocytochemical techniques. (33,39) . The ducts consist of an inner lining of epithelial cells and an outer lining of myoepithelial cells. The TEBs and some of the ABS consist of cells intermediate between epithelial and myoepithelial cells, and the alveoli consist of an inner lining of alveolar cells and an outer lining of myoepithelial cells. The myoepithelial cells are separated from the fatty stroma by a basement membrane. bFGF has been implicated in the development of the mammary gland in that it can stimulate the growth of certain rat, mouse, and human mammary cells in culture (22,26,34,37,40,46,47) . Moreover, bFGF and its specific receptors are produced preferentially by cultured rat myoepithelium-like cell lines (5,12). However, the role of bFGF in the development of the mammary gland in vivo is unknown. To approach this problem we have raised specific polyclonal antibodies to bFGF and have investigated their immunocytochemical distribution on histological sections taken from rat mammary glands at different developmental stages (32). The immunocytochemical staining of the different mammary structures for bFGF is related to the immunocytochemical staining for antibodies to human callus keratin and laminin. The latter two antibodies preferentially delineate the myoepithelial cells and basement membrane, respectively, within the mammary parenchyma (49).
Materials and Methods
Tissues and Histology. Animals were maintained on expanded Rat and Mouse Diet No. 1 (BP Ltd; Witham, Essex, UK) and water ad libitum. Those aged 1 and 6 days remained with their mothers. Both inguinal mammary glands from female Ludwig Wistar OLA rats (OLAC; Banbury, Oxfordshire, UK) were removed from pairs of freshly killed animals aged 1, 6, 21, 50, 60, and 90 days (32,49) . Both inguinal mammary glands were also removed from pairs of freshly killed female rats after 19 days of pregnancy or after 21 days of lactation; the latter rats were maintained with their suckling offspring until they were sacrificed (49).
If necessary when tissues were greater than 1 cm thick, tissues were cut into 1-cm thick slices, then were stretched over glass slides and fixed, usually in methacarn [60% methanol, 30% inhibisol (BDH Chemicals; Speke, Liverpool, UK), 10% acetic acid (v/v) (49)] or in formol saline for 24 hr at room temperature. The tissues were stored in 70% ethanol (v/v) at 4'C. They were processed in graded alcohols and inhibisol as described previously (49), except that the duration of each step was reduced to 45 min and the wax embedding was conducted at 56°C with two changes for a reduced duration of 1 hr each. The resultant blocks were stored at 4'C. Serial sections were then cut at 3 pm and processed as described previously (49) . except that sections were floated on a water bath at 40°C. The sections were mounted on slides which were dried at 37'C overnight and then stored at 4'C. They were dewaxed as usual, and every tenth serial section was stained with hematoxylin and eosin so that the glandular system could be traced and the different structures located (32, 41) .
Serology. Human recombinant bFGF (rbFGF) was prepared in a manner similar to that described previously for human recombinant acidic FGF (raFGF) by Ke et al. (23) . Briefly, the rbFGF was purified by heparin-Sepharose chromatography and reverse-phase or cation-exchange HPLC from lysates of bacterial cells harboring a PKK 233-2-bFGF construct (3) encoding amino acids 1-155 of human bFGF (I), to yield a single band of 17 KD on SDS-PAGE. The amino acid sequence was consistent with that of human bFGF and the recombinant protein possessed full biological activity (24) before immunization.
Antisera to rbFGF were prepared by immunization of Dutch rabbits with 300 pg pure human rbFGF. Animals were boosted periodically with 100 pg pure human rbFGF (28). The titer of the antisera was determined by enzyme-linked immunosorbent assay (ELISA), and high-titer antisera (greater than 1:2000) were pooled and purified by affinity chromatography. Human rbFGF was coupled to Affi-10 gel (BioRad; Hemel Hempstead, UK) (48), and bound antibodies (over 90% of the titer of the original antiserum) were eluted with 100 mM glycine, pH 2.5, into 2 ml 150 mM NaCI, 4 M %is, pH 8.0, 1% bovine serum altiumin (w/v). Immunoblotting of extracts of rat mammary cell lines partially purified by heparin-Sepharose chromatography demonstrated that the abow affinity-purified antiserum (1:20 dilution) recognized four polypeptides of apparent molecular weights 25, 23, 22, and 18 KD (Fernig DG et al., submitted for publication) , corresponding to the sizes of the four translation products of the bFGF mRNA (1435). This was the primary antibody to bFGF used in the results reported here. The same four polypeptides were also recognized by a protein A-Sepharose-purified rabbit antiserum (1:20 dilution) raised to human rbFGF (a gift of Drs. D. Moscatelli and D. B. Rifkin, New York University) (36) and by a crude commercial antiserum raised against bovine pituitary bFGF (1:200 dilution, after rehydration of the lyophilized antiserum according to manufacturer's instructions) (British Biotechnology; Oxford, UK). Furthermore, crossreaction in immunoblots of all of the above antisera to bFGF with human raFGF (23) was observed only at concentrations of raFGF that were 100-fold greater than the concentration of rbFGF necessary to generate the observed level of immunoreactivity. Polyclonal serum raised in rabbits against the 1-24 synthetic fragment of bovine pituitary bFGF has been characterized previously and was a gift of Dr. A. Baird (The Whittier Institute, La Jolla, CA) (18). Rabbit antisera to mouse laminin and human callus keratin were as described previously (49). Control solutions with anti-rbFGF serum and/or rbFGF and/or heparin were made as follows. The tonicity of pure rbFGF (100 pg in 600 p1 600 mM NaCI, 10 mM NaH2P04, pH 7.2) was adjusted by dilution with 10 mm NaH2P04, pH 7.2, to 150 mM NaCI, followed by concentration to 500 pl in an Amicon microconcentrator. Affinity-purified antiserum (100 pl) was mixed with an equal volume of isotonic rbFGF. In some experiments, after overnight incubation at 4°C. 2 p1 of a 200 pglml solution of porcine heparin (Sigma; Poole, UK) in water were added to yield a final concentration of 2 pg/ml. This concentration has been shown to effectively prevent the binding of rbFGF to its low-affinity heparan sulfate glycosaminoglycan receptors present on mammary cells (11). For control solutions for antisera to laminin and keratin, the absorbed antibodies were prepared by incubation with 100 pg/ml of the appropriate antigen at 37'C for 3 hr in isotonic buffers. The insoluble residues were removed by centrifugation before use (49). Anti-rbFGF serum absorbed with heparin and antisera to laminin and keratin absorbed with their appropriate antigens yielded no visible immunocytochemical staining on test sections of rat mammary glands. For all antibodies, non-immune sera (IgG fraction) were used as additional controls.
Immunochemistry. ELISAs were carried out on microtiter plates coated with 100 ng human rbFGF, 1 pg human raFGF, or 1 M/well heparin (28). Bound antibody was detected with an affinity-purified, alkaline phosphataseconjugated sheep anti-rabbit IgG (Sigma; St Louis, MO) and was measured colorimetrically at 405 nm in a microtiter-plate reader after development with phosphatase substrate (Sigma) according to the manufacturer's instructions.
For Western blotting, mammary glands were removed from 140-g virgin female rats and snap-frozen in liquid nitrogen. Frozen tissue was disrupted as before ( 5 ) , except that a Polytron (Kinematica; Lucerne, Switzerland) was used instead of a sonicator. The clarified supernatant from the high-speed centrifugation step was fractionated on a 1-ml column of heparin-Sepharose (Pharmacia; Uppsala, Sweden), as described previously ( 5 ) , except that the heparin-binding proteins were only eluted with 2 M NaCI. These eluates were desalted on a C2 Bond Elut minicolumn (Analytichem) and the protein eluted sequentially with acidified (0.1% vlv trifluoroacetic acid) 20%. 40%. and 60% acetonitrile (v/v), and finally with isopropanol. The pooled eluates were freeze-dried and the protein was fractionated by SDS-PAGE before transfer to nitrocellulose. The nitrocellulose filters were incubated with rabbit anti-rbFGF scrum and the bound antibody was visualized with honeradish peroxidase-conjugated sheep anti-rabbit IgG (Sigma) and diaminobenzidine (Sigma) (41).
Immunocytochemistry. Immunocytochemical detection of rabbit antisera to bFGF or control solutions was undertaken using the avidin-biotin complex (ABC) (21). The sections were d m e d in xylene and rehydrated through graded alcohols before being incubated for 15 min in 0.05% H202 (v/v) in methanol to inhibit endogenous peroxidases. After washing in water and PBS. pH 7.4. the sections were incubated overnight at room temperature with 1:20 diluted purified anti-rbFGF sera or 1:200 diluted unpurified commercial anti-bFGF in 0.5% bovine serum albumin (BSA) (w/v) in PBS. A second incubation using biotinylated donkey anti-rabbit Ig (Amersham) was carried out at a dilution of 1:200 for 1 hr at room temperature. After further washings of sections. they were finally incubated for 1 hr at room temperature with a complex of avidin-biotin-peroxidax (Dako; High Wycombc, UK) made up according to the manufacturer's instructions. After washing the sections, the brown coloration was developed for 5 min with 0.05% diaminobenzidine (DAB) (w/v) and 0.003% Hz02 (vlv) in 0.05 M Tris-HC1. pH 7.6. Sections were washed again and the cell nuclei counterstained blue with Mcyen' hemalum before mounting in DPX (BDH; Nottingham, UK) (41) . In parallel sections the brown staining was enhanced to a black coloration by including 0.0008% NiClz (wlv) with the DAB-H20z developing solution (2).
Immunocytochemical staining with rabbit antisera to keratin and laminin or their blocked control antisera was performed in the same way as that for antisera to bFGF, except that incubations with these primary antibodies or their blocked controls were conducted for 2 hr at room temperature and there was no need for enhancement with NiCIZ. All stained sections were viewed in a Reichert Polyvar microscope and photographed on Ilford Pan F film through a Kodak Wratten No. 44 filter (49).
In controls, the specificity of staining for each antibody was checked by the following. (a) Complete abolition of cytochemical staining was achieved by prior incubation of the purified antisera to rbFGF with heparin (sec above) and of antisera to keratin and laminin with the immunizing antigens (49). (b) Complete abolition of staining for the affinity-purified antiserum to rbFGF was achieved by incubation of the serum fraction that failed to bind to Affi-10 gel-rbFGF affinity columns. (c) Complete abolition of staining for all antibodies was also achieved when they were replaced by the corresponding pre-immune serum. (d) Increasing the concentration of all antibodies fivefold failed to alter the pattern of staining. (e) Control sections from the mammary glands of 50-day-old rats were stained in parallel with each antibody, and the overall results were rejected if the controls did not conform to established results with such material. (f) Two sections from at least 20 separate mammary structures of each type were stained and examined for all four antisera to bFGF. and the average result in terms of the percentage of cells/structures stained was recorded.
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Results
Elidation of Anti-r&FGF Serum and Immunochemical Staining
Affhity-purified antiserum raised in rabbits against human rbFGF bound in an ELISA assay to human rbFGF at dilutions as low as 1: l OOO and saturated this assay at dilutions of 1:40 to 1:20. The same antiserum failed to bind to human raFGF or to heparin in the same range of dilutions ( Figure la ). Western blotting of heparin-purified cell extracts of rat mammary glands with anti-human rbFGF serum produced only one immunoreactive component, which COmigrated with rbFGF on SDS-PAGE ( Figure Ib) .
Incubation of anti-rbFGF serum with formalin-fixed or methacarn-fixed rat brain and mammary tissues, which were processed and embedded in paraffin wax in the usual way, yielded poorly stained sections. The quality of the staining could not be improved by prior treatment of the sections with trypsin or hyaluronidase (data not shown). However, if the duration of the processing of the fixed specimens and the time of incubation in the wax were reduced, then reproducibly stained sections with all anti-bFGF sera were achieved (see Materials and Methods) (e.g., Figure 2a ). All subsequent results were reported in detail for our affinity-purified antibody to human rbFGF and were confirmed with the other antisera from other laboratories.
Immunocytochemical Staining of Rat Mammary Ducts
In the ducts of mammary glands from 50-day-old female rats, the anti-rbFGF serum stained the region immediately adjacent to the myoepithelial cells in the vicinity of the basement membrane; *.ool the epithelial and myoepithelial cells were either not stained or were stained only weakly, respectively. In addition, blood vessels and fibroblasts in the stroma were also stained (Figure 2a ). When the staining by anti-rbFGF serum was enhanced with N U , the intensity of staining of the basement membrane regions and of the myoepithelial cells and fibroblasts was increased over that without the NiC12, but the epithelial cells were still largely unstained (Figure 2b) . When NiCl2 was omitted from the reaction mixtures, it was easier to distinguish the thin, stained ribbon of basement membrane material from the adjacent weakly stained myoepithelial cells in cross-sections ( Figure 2c ) rather than in longitudinal sections of ducts. When NiC12 was included in the reaction mixtures, the staining of the myoepithelial cells was more clearly distinguishable in cross-sections of ducts (Figure 2c , inset) than in ducts in longitudinal sections (Figure 2b ). Prior addition of heparin to anti-rbFGF serum abolished the staining of the basement membrane regions, blood vessels, and fibroblasts (Figure 2d ). The anti-rbFGF serum fraction that failed to bind to rbFGF affinity columns did not stain any region of the maqmary gland (data not shown). However, prior addition of rbFGF to anti-rbFGF serum, even without NiC12, produced strong staining of the myoepithelium-like cells, basement membrane regions, blood vessels, and fat cells, as well as moderate staining of some of the epithelial cells (Figure 2e ). All this staining was abolished by including heparin (Figure 2f ; Table 1 ) but not laminin in the incubation mixtures or by replacing anti-rbFGF serum with the antiserum fraction that failed to bind to rbFGF affinity columns (data not shown). Results with the protein A-purified antibody to human rbFGF and the antibody to the 1-24 peptide, both from other laboratories, were identical to those with the affinity-purified anti-rbFGF serum. However, unpurified commercial antiserum to pituitary bFGF also stained the luminal surfaces of the ducts, and this staining was not abolished in incubations containing heparin (data not shown).
Immunocytochemical staining of longitudinal sections of a mammary duct with anti-laminin serum identified the basement membrane ( Figure 3a ). Adjacent serial sections stained with anti-rbFGF serum confirmed that the majority of this stain occurred in the basement membrane (Figure 3b ) and not in myoepithelial cells depicted with anti-callus keratin serum (Figure 3c ). This differential staining between anti-laminin and anti-rbFGF sera, on the one hand, and anti-callus keratin serum, on the other hand, was more easily observed in adjacent serial cross-sections of a duct. Little or no cytoplasmic staining for bFGF was observed in the cytoplasm of the myoepithelial cells, but staining was confined to the region of their basal surfaces (Figures 3d-3f ). Identical results were obtained with the other three antibodies to bFGF. Prior incubation of antisera to laminin and keratin with heparin failed to abolish their specific staining (data not shown).
Immunocytocbemical Staining of Ducts and Alveoli in Developing Rats
In growing mammary ducts from neonatal rats 1 day after birth, anti-rbFGF serum moderately stained both the inner cells that lined the lumen and the outer layer of cells; developing blood vessels and fat cells were also stained (Figure 4a ). This staining of the mam- The anti-bFGF serum was incubated with heparin (HEP) andlor recombinant bFGF (rbFGF), as described in Materials and Methods, before application to histological sections of mammary glands of 50-day-old female rats. b, basement membrane region; m. myoepithelid cells; c, TEB cells both central and peripheral; 4, 75-100% of parenchymal cellslstructures stained; 2, 25-50% of cellslstructures stained; -, <5% cellslstructures stained. mary parenchyma was punctate over the whole cell including the nucleus, and there was only weak staining of the basement membrane region (Figure 4a , inset). However, in mammary ducts from 6-day-old rats, most of the staining for bFGF was confined to the outer layer of myoepithelium-like cells, and there was little or no punctate staining of the inner epithelial cells. In occasional ducts of rats of this age, the staining was concentrated in the basement membrane region rather than throughout the myoepithelium-like cells (Figure 4b ). In the well-formed ducts of 21-day-old rats, virtually all of the staining for bFGF was concentrated in the basement membrane region, and there was little staining of the epithelial or myoepithelial cells (Figure 4c ). In rats aged 50 days and more (Table 2) , staining for bFGF completely encircled the ducts in the basement membrane region; the epithelial cells were relatively unstained. There were also more stained blood vessels and fibroblasts in the adjacent stroma than in younger rats (Figure 4d ).
When the female rats were mated, the larger ducts retained the basement membrane staining for bFGF, both in pregnancy (Figure 4e ) and in lactation (Eble 2). The alveoli in pregnancy ( Figure  4e ) and lactation (Figure 4f) were also circumscribed by a thin ribbon of staining for bFGF in the region of the basement membranelmyoepithelial cells. This staining surrounded about 25-50% and 5-25 % of individual alveoli in pregnancy and lactation, respectively (Eble 2). Because of the distension of the myoepithelial cells, particularly in the lactational state, it was difficult to distinguish whether anti-rbFGF serum stained the basement membrane and/or the myoepithelial cells, even when adjacent serial sections were stained with the requisite marker antibodies (data not shown). The protein A-purified antibody to human rbFGF, the anti-[ 1-24] peptide serum, and the unpurified commercial serum to bovine pituitary bFGF yielded the same results, except that the unpurified commercial serum also stained the luminal surfaces of ducts and alveoli and their secretions. This luminal and secretory staining was not inhibited by incubations that included heparin, whereas all other stainings by the four antibodies were suppressed with heparin. Incubation of the anti-rbFGF serum fraction that failed to bind to rbFGF affinity columns also produced no staining (data not shown). b2 ,c4  b2,c4 bl,e4,m4,(b2) Result shown for growing AB, that for non-growing AB shown in parentheses.
Immunocytochemical Staining of Budded Structures of Mammary Glands from Developing Rats
TEBs occurred most frequently in rats of age 21 days, and thereafter progressively subdivided and differentiated into alveolar buds. TEBs had disappeared in 90-day-old rats ('kble 2). Antiserum to rbFGF stained, to the same extent, both the inner central cells and the outer, more peripheral cells of TEBs, when observed both in longitudinal (Figure 5a ) and in cross-section (Figure 5b) . At the junction of the TEBs and their subtending ducts, this antibody stained intensely the region of the basement membrandmyoepithelial cells. In contrast, the peripheral region of the TEBs, distal to the ducts, showed no such discriminatory staining ( Figure  5a ). The extent of the staining in the basement membrane/myoepithelial cells proximal to the subtending ducts increased with the age of the rat, until the TEBs subdivided into ABS (Table 2) . Capillaries and fibroblasts immediately adjacent to the TEBs were also strongly stained by anti-rbFGF serum (Figure 5b) . Heparin inhibited the staining achieved by anti-rbFGF serum alone (Table  1) . When the incubations contained both rbFGF and anti-rbFGF serum, there was no increase in staining of the outer peripheral cells, unlike that observed for the myoepithelial cells of the mature ducts (Table 1 ). The staining intensities of all the cells of the TEBs were similar to one another and were similar to those obtained with anti-rbFGF serum alone (Figure 5c ). The inclusion of heparin with rbFGF and anti-rbFGF serum completely abolished this staining (Figure 5d ). The staining pattern of ABS with anti-rbFGF serum also varied with age and development of the rat. In 60-day and particularly in mature 90-day-old rats, in which the ductal system was almost complete, antiserum to rbFGF stained a thin ribbon of basement membrane material which encircled the ABS (Figure se) . The older the rat, the less fragmented this stain appeared ( Table 2 ). In younger >O-day-old, in some 60-day-old rats, and in pregnant rats, in which the ductular system was growing and the ABS were subdivid-ing further, anti-rbFGF serum moderately stained both the epithelial and myoepithelium-like cells, as well as the basement membrane region. Blood vessels were also particularly well stained at this stage ( Figure Sf ). There were gradations between these two extremes of staining pattern for the ABS. Similar staining patterns for TEBs and ABS were obtained with the three other antibodies to bFGF. All staining was abolished by inclusion of heparin with anti-rbFGF and by the fractions of anti-rbFGF serum that failed to bind to rbFGF affinity columns.
Discussion
The immunocytochemical staining pattern for bFGF within the mammary parenchyma is rather heterogeneous. This heterogeneity is not a simple artifact of tissue preservation, owing, for example, to lack of accessibility of the antibody to its antigen or to its crossreactivity with proteins other than bFGF, for the following reasons. (a) The same pattern of staining, although less intense, is achieved with tissues preserved in formol saline instead of methacarn. (b) Increasing the concentration of the antisera to rbFGF fivefold fails to change the overall pattern. (c) Limited treatment of sections with proteases or hyaluronidase fails to alter the immunocytochemical staining pattern. (d) Four independently isolated antisera give a similar pattern of staining. (e) Complete abolition of staining for bFGF is achieved with serum fractions of anti-rbFGF that fail to bind to rbFGF affinity columns. (f) All staining is blocked by heparin, which is known to bind specifically to members of the FGF family (7, 36) . This inhibition of binding is not due to contaminating anti-heparin serum raised to low levels of heparin in the original rbFGF preparations, since the anti-rbFGF serum fails to bind to heparin in ELISA assays. This inhibition may therefore result from heparin binding to the immunoreactive bFGF present in the mammary gland, masking antigenic sites. That this effect is specific for bFGF is demonstrated by the inability of heparin to alter the staining pattern observed with antisera to laminin and keratin. Therefore, two major immunocytochemical patterns for bFGF have been observed in the mammary parenchyma: that in non-growing and that in growing structures.
Within the more mature resting ducts and secretory alveoli, bFGF is located predominantly in the basement membrane/myoepithelial cell region, in agreement with the results of Gomm et al. in human breast (17) . In the ducts, the majority of the staining for anti-rbFGF serum is coincident with that for anti-laminin serum, a marker for the basement membrane (49). In the alveoli, although serial sections have been stained for separate markers for the basement membrane and for the myoepithelial cell, the distended configuration of the myoepithelial cells in alveoli from pregnant and lactating glands has precluded an unambiguous identification. Moreover, the weak staining for antisera to rbFGF on ductal myoepithelial cells can be enhanced by chemical means. The weak staining suggests the presence of a considerably reduced amount of bFGF in the myoepithelial cell compared with that in the basement membrane. The association of bFGF with the basement membrane surrounding blood vessels and several other tissues has been reported previously (9, 15) . However, the occurrence of bFGF in basement membranes underlying epithelial tissues of adult mammals is comparatively rare (9), compared with its more common occurrence underlying epithelial tissues in the fetus. In the latter instance, the developing epithelia and mesenchyme are often in juxtaposition (18) . Such a situation also occurs within the developing mammary gland after birth, continuing through adolescence and pregnancy. Within the growing mammary ducts of 1-day-old neonatal rats and in growing TEBs and, to a lesser extent, in growing ABS, the inner and outer cells are moderately stained to a similar extent by anti-rbFGF serum. Staining for bFGF in the basement membrane region is not apparent. In these examples of growing mammary structures (44), the cells are rather heterogeneous and, in particular, the outer peripheral cell layer consists of cells intermediate in characteristics between epithelial and myoepithelial cells (10, 32, 50) . It is only in ducts from neonatal rats 5 or 6 days after birth (49), and in non-growing ABS and alveoli (32), that the outer peripheral cell layer becomes composed of well-differentiated myoepithelial cells. At these developmental stages, the majority of the staining for bFGF reverts to the basement membrane/myoepithelial cell region. Therefore, the presence of immunoreactive bFGF may be associated with proliferating intermediate cells, some of which may ultimately give rise to myoepithelial cells. A changed cellular distribution of immunoreactive bFGF between growing and quiescent cells has also been recently observed for human placental cells in vitro and in vivo (8) .
The staining patterns of the developing rat mammary gland with antibodies to rbFGF are broadly in agreement with the cellular distribution of bFGF in cultured rat mammary cell lines. Thus, the majority of the bFGF is produced by the myoepithelium-like cell lines from normal glands and benign tumors, very little is produced by the epithelial cell lines, and much of the bFGF is found extracellularly, probably in association with heparan sulfate glycosaminoglycans (5). Cell lines intermediate both in characteristics and in steps in a differentiation pathway between epithelial and myoepithelium-like cells in culture also produce intermediate levels of bFGF (5). These intermediate cell lines resemble the morphologically intermediate cells in growing TEBs in vivo (32). They also possess the capacity to differentiate to epithelial cells or to myoepithelium-like cells (42), with a corresponding decrease or increase, respectively, in production of bFGF in vitro (5).
In contrast to most antisera and their immunizing antigens (e.g., antisera to laminin and callus keratin), when any one of the four antisera to bFGF is incubated with rbFGF, it fails to abolish the immunocytochemical staining produced by this antiserum alone. In addition to the failure of rbFGF to inhibit binding of anti-bFGF sera to the basement membrane region of non-growing ducts, mixtures of rbFGF and anti-bFGF serum increase the staining of the myoepithelial cells and, to a lesser extent, that of the epithelial cell. These results may reflect the cells' possession of unoccupied binding sites for bFGF in the resting ducts. The majority of such unoccupied binding sites probably correspond to the low-affinity heparan sulfate glycosaminoglycan receptors of the cellular plasma membrane and of the extracellular matrix/ basement membrane, as described previously for rat mammary cell lines (11.12). The cell staining of proliferating intermediate cells and its failureto be enhanced by mixtures of rbFGF and anti-rbFGF serum may therefore reflect that similar cell binding sites are now occupied by bFGF in growing mammary structures, particularly in the TEBs. It has been postulated that the binding of bFGF to heparan sulfate glycosaminoglycans of the basement membrane/extracellular matrix of vascular endothelial cells represents a storage depot for bFGF, and that on its loss/destruction, bFGF may be released to stimulate endothelial cell growth (4.6). Similar considerations may apply in the resting and growing structures of the mammary gland.
In the cultured rat mammary cell lines, the expressipn of the two types of extracellular receptor for bFGF, the high-affinity signaling receptor and the low-affinity heparan sulfate-glycosaminoglycan receptor, also correlates with the degree of differentiation of the cells towards the myoepithelial phenotype. Whereas epithelial cells from normal glands and benign tumors possess neither receptor, a graded increase in receptor number is observed across the series of intermediate cell lines (11, 12) . Therefore, the intermediate and myoepithelial-like cell lines not only produce bFGF but can also be stimulated by bFGF to proliferate at levels consistent with those of an autocrine/paracrine growth regulator. The epithelial cell lines from normal and benign tumors fail in both of these respects (5, 12, 46) . Therefore, the presence of immunoreactive bFGF in the intermediate cells of growing TEBs is consistent with its role as a growth regulator in vivo. Proliferating fibroblasts and blood vessels adjacent to growing ducts of neonatal rats and to TEBs of adolescent rats also possess immunoreactive bFGF. Whether development of such mesenchymal systems influences the development of nearby growing epithelial structures within the mammary parenchyma or vice versa, as suggested for embryonic and fetal development (18, 25, 45) , is uncertain.
In conclusion, the heterogeneous staining for immunoreactive bFGF in the developing rat mammary gland may reflect differences in states of cell differentiation. Alternatively, this heterogeneity of staining may be due to differences in cell function and/or to position within the parenchyma of the mammary gland. 
